VPC Researchers Receive CIHR Project Grants for Advancing Research.

Date Posted

The outcome of the CIHR Spring 2024 project grant competition has been revealed, with 373 research grants and 68 priority grants approved, amounting to a $325 million investment. We extend our congratulations to the VPC researchers who have been successful in securing project grants.

Project Grants

aRtificial intelligence-driven computational pathology platform for blAdder Cancer subTyping (REACT)
Principal investigators: Dr. Peter Black, Dr. Gang Wang, Dr. Ali Bashashati

Copper Associated Immunogenic Cell Death: Improving the Therapeutic Potential of Immune Check Point Inhibitors for the Treatment of Metastatic Bladder Cancer
Principal investigators: Dr. Marcel Bally, Dr. Laura Evgin 
Co-investigators: Dr. John Bell, Dr. Peter Black, Dr. Bernhard Eigl

An integrated AI-powered platform for cell analytics
Principal investigator: Dr. Mads Daugaard

Lin28b as a therapeutic target for prostate cancer progression
Principal investigator: Dr. Xuesen Dong
Co-investigators: Dr. Art Cherkasov, Dr. Faraz Hach, Dr. Suzana K. Straus

Interplay between ASCL1 and chromatin remodeling complex in prostate cancer lineage plasticity
Principal investigator: Dr. Amina Zoubeidi
Co-investigators: Dr Faraz Hach, Dr Shaghayegh Nouruzi